Insulet Closes $450 Million Senior Notes Issuance
I'm PortAI, I can summarize articles.
Insulet Corporation has successfully closed its issuance of $450 million in 6.50% Senior Notes due 2033, with net proceeds of approximately $444 million. The company also amended its Credit Agreement, extending revolving credit commitments to March 20, 2030, and increasing them to $500 million. Additionally, Insulet repurchased $419 million of its Convertible Senior Notes due 2026, affecting its outstanding debt. Insulet specializes in innovative insulin delivery systems, including the Omnipod Insulin Management System, and currently has a market cap of $18.29 billion.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments